Coagulation abnormalities in patients with hip osteonecrosis

Orthopedic Clinics of North America

Volumn 35, Issue 3, 2004, Pages 265-271

  Korompilias, Anastasios V ^a   Ortel, Thomas L ^b   Urbaniak, James R ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; FEMUR HEAD NECROSIS; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; MALE; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM;

EID: 3242701182     PISSN: 00305898     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ocl.2004.02.004     Document Type: Review

References (38)

1. Mont M.A., Hungerford D.S. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg [Am]. 77:1995;459-474
2. Jones J.P. Concepts of etiology and early pathogenesis of osteonecrosis. Urbaniak J.R., Jones J.P. Jr. Instructional course lectures. The American Academy of Orthopaedic Surgeons. 1994;499-512 The American Academy of Orthopaedic Surgeons, Park Ridge (IL)
3. Glueck C.J., Crawford A., Roy D., Freiberg R., Glueck H., Stroop D. Association of antithrombotic factor deficiencies and fibrinolysis with Legg-Perthes disease. J Bone Joint Surg [Am]. 78(1):1996;3-13
4. Glueck C.J., Freiberg R., Glueck H.I., Henderson C., Welch M., Tracy T., et al. Hypofibrinolysis: a common major cause of osteonecrosis. Am J Hematol. 45(2):1994;156-166
5. Van Veldhuizen P.J., Neff J., Murphey M.D., Bodensteiner D., Skikne B.S. Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. Am J Hematol. 44(4):1993;243-248
6. Korompilias A.V., Gilkeson G.S., Ortel T.L., Seaber A.V., Urbaniak J.R. Anticardiolipin antibodies and osteonecrosis of the femoral head. Clin Orthop. 345:1997;174-180
7. Korompilias A.V., Ortel T.L., Gilkeson G.S., Coogan P.G., Gunneson E.E., Urbaniak J.R., et al. Hypercoagulability and osteonecrosis. Urbaniak J.R., Jones J.P. Jr. Osteonecrosis: etiology, diagnosis, and treatment. 1997;111-117 American Academy of Orthopaedic Surgeons, Rosemont (IL)
8. Marcus N.D., Enneking W.F., Massam R.A. The silent hip in idiopathic aseptic necrosis. Treatment by bone grafting. J Bone Joint Surg [Am]. 55(7):1973;1351-1366
9. De Ronde H., Bertina R.M. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost. 72(6):1994;880-886
10. Joyner K.A., Ortel T.L. A sensitive dRVVT reagent system for the detection of lupus anticoagulants. Clin Appl Thromb Hemost. 1:1995;73-75
11. Loizou S., McCrea J.D., Rudge A.C., Reynolds R., Boyle C.C., Harris E.N. Measurement of aCLA by an enzyme-linked immunoabsorbent assay (ELISA): standardization and quantitation of results. Clin Immunol Immunopathol. 62(3):1985;738-745
12. Loscalzo J. Pathogenesis of thrombosis. Beutler E., Lichtman M.A., Coller B.S., Kipps T.J. Williams hematology. 5th edition:1995;1525-1531 McGraw-Hill, New York
13. McKee P.A. Disorders of blood coagulation. Wyngaarden J.B., Smith L.H. Jr. Cecil textbook of medicine. 17th edition:1985;1040-1058 W.B. Saunders, Philadelphia
14. Dahlback B., Carlson M., Svensson P.J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A. 90(3):1993;1004-1008
15. Koster T., Rosendaal F.R., de Ronde H., Briet F., Vandenbroucke J.P., Bertina R.M. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet. 342:1993;1503-1506
16. Svensson P.J., Dahlback B. Resistance to activated protein C as basis for venous thrombosis. N Engl J Med. 330(8):1994;517-522
17. Cumming A.M., Tait R.C., Fildes S., Yoong A., Keeney S., Hay C.R. Development of resistance to activated protein C during pregnancy. Br J Haematol. 90(3):1995;725-727
18. Berg K. Lp(a) lipoprotein : an overview. Scanu A.M. Lp(a). 1990;1-23 Academic Press, San Diego (CA)
19. Hajjar K.A., Nachman R.L. The role of Lp(a) in atherogenesis and thrombosis. Annu Rev Med. 47:1996;423-442
20. Hajjar K.A., Gavish D., Breslow J.L., Nachman R.L. Lipoprotein (a) modulation endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature. 339:1989;303-305
21. Zalavras Ch, Dailiana Z., Elisaf M., Bairactari E., Vlachogiannopoulos P., Katsaraki A., et al. Potential aetiological factors concerning the development of osteonecrosis of the femoral head. Eur J Clin Invest. 30(3):2000;215-221
22. Bick R.L., Pegram M. Syndromes of hypercoagulability and thrombosis. Semin Thromb Hemost. 20(1):1994;109-132
23. Hughes G.R.V. The antiphospholipid syndrome: ten years on. Lancet. 342:1993;341-344
24. Lockshin M.D. Answers to the antiphospholipid syndrome? N Engl J Med. 332(15):1995;1025-1027
25. Asherson R.A., Jungers P., Liote F. Ischaemic necrosis of bone associated with the "lupus anticoagulant" and antibodies to cardiolipin [abstract]. In: Programs and abstracts of the 16th International Congress of Rheumatology, Sydney, Australia, 1985. p. 282
26. Lavilla P., Gil A., Khamashta M.A., Vazquez J.J. Necrosis osea avascular y lupus eritematoso sistemico. Rev Clin Esp. 181(5):1987;289-290
27. Asherson R.A., Khamashta M.A., Ordi-Ros J., Derksen R.M., Machin S.J., Barquinero J., et al. "Primary" antiphospholipid syndrome: major clinical and serological features. Medicine. 68(6):1989;366-374
28. Asherson R.A., Liote F., Page B., Meyer O., Buchanan M., Khamashta M.A., et al. Avascular necrosis of bone and APLA in systemic lupus erythematosus. J Rheumatol. 20(2):1993;284-288
29. Vela P., Battle E., Salas E., Marco P. Primary antiphospholipid syndrome and osteonecrosis. Clin Exp Rheumatol. 9(5):1991;545-546
30. Seleznick M.J., Silveira L.H., Espinoza L.R. Avascular necrosis associated with anticardiolipin antibodies. J Rheumatol. 18(9):1991;1416-1417
31. Alijotas J., Argemi M. Barguinero: Kienbock's disease and APLA. Clin Exp Rheumatol. 8(3):1990;297-298
32. Reyes H., Dearing L., Bick R.L., Shoenfeld Y., Peter J.B. Laboratory diagnosis of antiphospholipid syndromes. Clin Lab Med. 15(1):1995;85-108
33. Harris E.N., Chan J.K., Asherson R.A., Aber V.R., Charavi A.E., Hughes G.R. Thrombosis, recurrent fetal loss and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med. 146(11):1986;2153-2156
34. Kalunian K.C., Peter J.B., Middlekauf H.R., Sayre J., Ando D.G., Mangotich M., et al. Clinical significance of a single test for anticardiolipin antibodies in patients with lupus erythematosus. Am J Med. 85(5):1988;602-608
35. Bick R.L., Baker W.F. ACLA and thrombosis. Hematol Oncol Clin N Am. 6(6):1992;1287-1299
36. Harris E.N., Hughes G.R.V., Charavi A.E. Antiphospholipid antibodies: an elderly statesman dons new garments. J Rheumatol. 14(Suppl 13):1987;208-213
37. Tektonidou M.G., Malagari K., Vlachoyianopoylos P.G., Kelekis D.A., Moutsopoulos H.M. Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use. Arthritis Rheum. 48(3):2003;732-736
38. Korompilias A.V., Gilkeson G.S., Seaber A.V., Urbaniak J.R. Hemorrhage and thrombus formation in early experimental osteonecrosis. Clin Orthop. 386:2001;11-18